Belantamab mafodotin induces immunogenic cell death within 24 h post-administration in newly diagnosed multiple myeloma patients.
Ioannis V KostopoulosAntonis KakalisAnastasios BirmpilisNikolaos AngelisNikolaos Orologas-StavrouPantelis RousakisChrysanthi PanteliMaria GavriatopoulouEfstathios KastritisMeletios- Athanasios DimopoulosOurania TsitsilonisEvangelos TerposPublished in: American journal of hematology (2022)